Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload

Name: Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
Published: 2008
License: Public Domain

Novartis Pharmaceuticals · 2008

ClinicalTrials.gov · Datasets · License: Public Domain · 2008

Open Source ↗

adults hematopoietic-stem-cell-transplantation

iron overload, hematopoietic stem cell transplantation, hct, chelators, icl670, deferasirox, serum ferritin, lic, transfusional hemosiderosis, blood transfusions, adults, iron chelation

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 881352
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.